Test ID FSAR2 SARS-CoV-2 Neutralizing Antibody
Ordering Guidance
Molecular testing is recommended for diagnosis of coronavirus disease 2019 (COVID-19) in symptomatic patients.
Specimen Required
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions: Draw blood in a serum gel tube(s), plain red-top tube(s) is acceptable. Centrifuge and aliquot serum; send one aliquot. DO NOT heat-inactivate. Ship 1 mL serum in a plastic vial, frozen.
Useful For
Detection of specific neutralizing antibodies capable of inhibiting SARS-CoV-2-virus.
Method Name
Virus Neutralizing Antibody Test
Reporting Name
SARS-CoV-2 Neutralizing AntibodySpecimen Type
SerumSpecimen Minimum Volume
0.2 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Frozen (preferred) | 30 days | |
Refrigerated | 72 hours | ||
Ambient | 24 hours |
Reference Values
22 - 20,862 IU/mL
Performing Laboratory
Imanis Life SciencesTest Classification
This test was developed, and its performance characteristics determined by Imanis Life Sciences, LLC in a manner consistent with CLIA requirements. This test has not been reviewed, cleared, or approved by the U.S. Food and Drug Administration.CPT Code Information
86409
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
FSAR2 | SARS-CoV-2 Neutralizing Antibody | 95410-7 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
FSAR2 | SARS-CoV-2 Neutralizing Antibody | 95410-7 |
NY State Approved
NoDay(s) Performed
Monday through Friday